(Q54899847)

English

KH OS R2

cell line

KHOSR2
KHOS(R2)
KHOS R2
KHOSMR

In more languages

default for all languages

No label defined

No description defined

Statements

1 reference

Cellosaurus release 49

14 July 2024

cancer cell line

1 reference

Cellosaurus release 49

14 July 2024

parent cell line

1 reference

Cellosaurus release 49

14 July 2024

described by source

Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J.

1 reference

Cellosaurus release 49

14 July 2024

Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.

1 reference

Cellosaurus release 49

14 July 2024

Programmed cell death ligand 1 expression in osteosarcoma

1 reference

Cellosaurus release 49

14 July 2024

A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells.

1 reference

Cellosaurus release 49

14 July 2024

established from medical condition

1 reference

Cellosaurus release 49

14 July 2024

derived from organism type

1 reference

Cellosaurus release 49

14 July 2024

Identifiers

1 reference

Cellosaurus release 49

14 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54899847&oldid=2258383986"